DELOS PHARMACEUTICALS
Delos Pharmaceuticals, Inc. discovers and develops novel polyketide-based therapies to treat chronic disease. The company focuses on novel biological mechanisms that can be used to treat aging-related disease by addressing the basis for disease initiation and progression, such as oxidative, cellular, and environmental stress. Delos Pharmaceuticals, Inc. was incorporated in 2012 and is based in Novato, California.
DELOS PHARMACEUTICALS
Industry:
Biopharma Pharmaceutical
Founded:
2012-01-01
Address:
Novato, California, United States
Country:
United States
Total Employee:
1+
Status:
Closed
Contact:
415-209-2055
Total Funding:
785.69 K USD
Similar Organizations
Causeway Therapeutics
A bio pharmaceutical spin out emerging.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
i2 Pharmaceuticals
i2 Pharmaceuticals, a biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
STRAND Clinical Technologies
A Pharmaceuticals Company .
Current Advisors List
Current Employees Featured
Founder
More informations about "Delos Pharmaceuticals"
DELOS PHARMACEUTICALS, INC. | Aeonian Pharmaceuticals
DELOS PHARMACEUTICALS, INC. DUNS 079402738 / 07-940-2738 Aeonian Pharmaceuticals AEOVIAN PHARMACEUTICALS, INC. NCAGE Code: 74VF8. DELOS PHARMACEUTICALS, …See details»
Delos
An independent wholly owned Delos subsidiary driving market transformation through WELL, the world’s leading certification platform for healthy buildings and organizations. Well Living Lab …See details»
Delos Pharmaceuticals - Contacts, Employees, Board Members
Organization. Delos Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of …See details»
Delos Pharmaceuticals Stock Data, Filings, Earnings, News
Delos Pharmaceuticals Company Profile Company profile. Employees. Incorporated. Delaware. Location. California. Fiscal year end. Dec 31. Former names. Delos Pharmaceuticals, Inc. …See details»
Delos Pharmaceuticals - Funding, Financials, Valuation & Investors
Organization. Delos Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 1. ... Delos …See details»
Delos – Manifesting Health, Wellness, and Wonder
DELOS Therapeutics Manifesting Health, Wellness, and Wonder DELOS Therapeutics We are a multi-disciplinary group committed to developing and implementing rigorous scientific studies …See details»
Delos Pharmaceuticals, Inc. | AUM 13F
Delos Pharmaceuticals, Inc. CIK # 0001710088: EDGAR Form CIK 2011 - 2024; DSee details»
Buck Institute Announces its Founding Partnership with Delos ...
Oct 25, 2012 “Delos Pharmaceuticals focuses on novel biological mechanisms that can be used to treat aging-related disease by addressing the basis for disease initiation and progression, …See details»
Delos Therapeutics - Company Profile - Tracxn
Delos Therapeutics - Developer of psychedelic therapeutics for neurological disorders. Delos Therapeutics has 413 competitors. Delos Therapeutics - Company Profile - TracxnSee details»
Delos Therapeutics - LinkedIn
DELOS Therapeutics is dedicated to rigorously researching and developing psychedelic medicines with the aim of producing commercially available treatments that are safe, effective, …See details»
Delos Pharmaceuticals - Updates, News, Events, Signals & Triggers
Organization. Delos Pharmaceuticals . Connect to CRM . Save . Summary Financials People Technology Signals & News Similar Companies. Recent News & Activity. Edit Recent News & …See details»
Research programme: mTOR inhibitors - Delos Pharmaceuticals
Delos Pharmaceuticals, under an exclusive license from Biotica Technology, is developing rapamycin analogues as inhibitors of mTOR (mammalian target ofSee details»
LipoSeuticals closes Series A for novel drug delivery tech
Jun 29, 2017 In connection with the round, Lan Bo Chen of Delos Capital plans to join the company’s board. “This exciting opportunity enables the LSI management team and Delos to …See details»
Greybrook and Canadian Investment Partners Invest in Delos to …
Apr 15, 2021 “With a portfolio of residential and commercial real estate at various stages of development totalling in aggregate over 43 million square-feet of projected density, and our …See details»
DELOS FORMULATION TECHNOLOGY, THE BEST OPTION FOR …
15 November 2021 DELOS FORMULATION TECHNOLOGY, THE BEST OPTION FOR YOUR NANOMEDICINES. As the report in Farmaindustria magazine indicates, incremental …See details»
Delos Pharmaceuticals - Crunchbase
A Pharmaceuticals Company. Start Free Trial . Chrome ExtensionSee details»
Tim Xiao Profile: Contact Information & Network | PitchBook
Mr. Tim Xiao is a Founding Team Member and serves as Partner at Delos Capital Partners. He serves as Board Observer at Allecra Therapeutics. ... Pharmaceuticals: Shanghai, China: …See details»
Delos - Company Profile - Tracxn
Dec 27, 2024 Delos - Provider of solutions for indoor air purifiers. Raised a total funding of $541M over 10 rounds from 10 investors. Valued at $800M. Founded by Paul Scialla in the …See details»
Greybrook and Delos Partner to Accelerate Health in Canadian …
Apr 20, 2021 “With a portfolio of residential and commercial real estate at various stages of development totalling in aggregate over 43 million square feet of projected density, and our …See details»